Advances in Rare Diseases Biomarkers

A rare disease is a health condition with a lower prevalence than common diseases. The World Health Organization defines a rare disease as one that strikes fewer than 65 per 100,000 people. However, their combined effect is significant: around 7,000 rare diseases affect approximately 350 million peo...

Descripció completa

Guardat en:

Dades bibliogràfiques
Format:	Online
Idioma:	anglès
Publicat:	MDPI - Multidisciplinary Digital Publishing Institute 2025
Matèries:	galectin-3 aminotransferase calprotectin urine primary sclerosing cholangitis inflammatory bowel disease inborn errors of metabolism (IEMs) maple syrup urine disease (MSUD) genetic testing newborn screening alloisoleucine methionine sulfoxide LysoPI untargeted metabolomics liquid chromatography high-resolution mass spectrometry extracellular vesicles (EVs) uveal melanoma aqueous humor (AH) liquid biopsy ocular cancer diagnosis rare disease PXE threshold PPi PPi quantification toll-like receptors (TLRs) epiretinal membranes (ERMs) vitreous complement fragments extra-cellular matrix (ECM) innate immunity inflammation tissue remodeling vitreoretinal diseases progressive supranuclear palsy microRNAs biomarkers atypical parkinsonian disorders obesity ciliopathy biomarker RASopathies molecular signatures precision medicine personalized diagnostics gastric cancer intestinal metaplasia metabolomics metabolite profiling hemophilic arthropathy biomarkers in hemophilic arthropathy joint lesions in hemophilia thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPK Mental health services
Accés en línia:	ONIX_20250220_9783725824120_262
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!

Advances in Rare Diseases Biomarkers

Ítems similars